UB

Urmil Bhambri

Active Director Director DIN 08103790
DIN 08103790 First appointment Apr 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2018
Shareholding value •••• Premium profile

About Urmil Bhambri

Data last updated:

Urmil Bhambri is a Director at Acuracon Health Sciences Private Limited (since 2018). The company operates in Healthcare. Acuracon Health Sciences Private Limited reported revenue of ₹4.56 Cr (FY 2024).

DIN 08103790
Primary Designation Director
Industry Healthcare
First Appointment 05 Apr 2018
Oldest Company Age 8 yrs
Largest company Acuracon Health Sciences Private Limited · ₹4.56 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Apr 20182018₹4.56 Cr (FY 2024)Active

Board colleagues of Urmil Bhambri

Directorship timeline

Open interactive timeline →
Acuracon Health Sciences Private Limited
Premium access

Shareholding and investment profile for Urmil Bhambri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Urmil Bhambri

Urmil Bhambri currently holds 1 directorship: Acuracon Health Sciences Private Limited (Director, since 05 Apr 2018, revenue ₹4.56 Cr (FY 2024)).

Urmil Bhambri was first appointed on 05 Apr 2018 as Director at Acuracon Health Sciences Private Limited.

The current boards of Urmil Bhambri's companies include Kewal Krishan Bhambri (Acuracon Health Sciences Private Limited), Umang Bhambri (Acuracon Health Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available